Colorectal cancer is a significant health issue in France, with nearly 47,582 new cases diagnosed each year, making it one of the most frequent cancers in the country. It is also the second leading cause of cancer deaths, resulting in approximately 17,000 fatalities annually. Unfortunately, many people remain unaware of the signs and symptoms, such as abdominal pain and fatigue, which can often go unnoticed until the disease advances. However, if detected early, the survival rate is impressively high, with 90% of cases curable when caught at an early stage.

To combat the rising incidence of this disease, France has implemented a national screening program aimed at individuals aged 50 to 74, who are at a higher risk for developing colorectal cancer. This program, initiated in April 2015, offers biennial access to a quantitative fecal immunochemical test (FIT), which is followed by a colonoscopy if results indicate concern. Despite the availability of these screening methods, the article emphasizes that participation rates remain low, underscoring the need for greater public awareness regarding the importance of early detection and proactive health measures.

Overall, the article highlights the critical role that regular screening can play in reducing the impact of colorectal cancer in France. By encouraging the at-risk population to participate in the screening program, it is hoped that fewer lives will be lost to this preventable disease, thus addressing a pressing public health concern in the country.